Cell Line : NCI-H250
Cellosaurus Index : CVCL_1554
Cellosaurus ID : NCI-H250
GDSC1 Name
, GDSC2 Name
: NCI-H250
CCLE Name
: NCIH250_LUNG
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H250 | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 5-Fluorouracil | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H250 | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | Afatinib | GDSC2 | 0.0020 | 4.0000 |
|
| NCI-H250 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H250 | Alisertib | GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H250 | Alpelisib | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H250 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| NCI-H250 | Avagacestat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Axitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD1208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD1332 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD2014 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | AZD4547 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD5438 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD5582 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD6482 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD6738 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | AZD7762 | GDSC2 | 0.0010 | 2.0000 |
|
| NCI-H250 | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | BI-2536 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H250 | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Bicalutamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Bleomycin | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | BMS-345541 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | BMS-536924 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | BMS-754807 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H250 | Bosutinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | BX795 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H250 | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | CCT-018159 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | CCT007093 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | CHIR-99021 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Crizotinib | GDSC2 | 0.0010 | 8.0000 |
|
| NCI-H250 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Dabrafenib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Dacarbazine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H250 | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| NCI-H250 | Dactolisib | GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H250 | Daporinad | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Docetaxel | GDSC2 | 0.0000 | 3.0000 |
|
| NCI-H250 | Doramapimod | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H250 | EHT-1864 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H250 | Elesclomol | GDSC2 | 0.0002 | 0.2000 |
|
| NCI-H250 | Entinostat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Erlotinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H250 | Foretinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Fulvestrant | GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H250 | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Gefitinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | Gemcitabine | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | GSK1904529A | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H250 | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK269962A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| NCI-H250 | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H250 | GW441756 | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | I-BET-762 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | IAP_5620 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | IOX2 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H250 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | JNK Inhibitor VIII | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | JQ1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H250 | KU-55933 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H250 | Lenalidomide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Lestaurtinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | LGK974 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Linsitinib | GDSC2 | 0.0025 | 10.0000 |
|
| NCI-H250 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H250 | LY2109761 | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H250 | Methotrexate | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H250 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H250 | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | MK-2206 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H250 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Motesanib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Navitoclax | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | Nelarabine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H250 | Nilotinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | NU7441 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Nutlin-3a | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Obatoclax Mesylate | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Olaparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | OSI-027 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Oxaliplatin | GDSC2 | 0.0100 | 20.0000 |
|
| NCI-H250 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H250 | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | Palbociclib | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H250 | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H250 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | PD0325901 | GDSC2 | 0.0003 | 2.5000 |
|
| NCI-H250 | PD173074 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Pevonedistat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | PF-4708671 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | PFI-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Pictilisib | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H250 | Piperlongumine | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | PLX-4720 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Rapamycin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H250 | Refametinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H250 | RO-3306 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| NCI-H250 | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | Ruxolitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | SB505124 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | SB590885 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Selumetinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Sepantronium bromide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Serdemetan | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | SGC0946 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H250 | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | SL0101 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | SN-38 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Sorafenib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H250 | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Talazoparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Tamoxifen | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Tanespimycin | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H250 | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Temozolomide | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | Temsirolimus | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Teniposide | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | Topotecan | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | Trametinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Tretinoin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H250 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Veliparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H250 | Vincristine | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H250 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H250 | Vismodegib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Vorinostat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H250 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | XAV939 | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H250 | YK-4-279 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | ZM447439 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H250 | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC